Bausch + Lomb recalls some of its implantable eye lenses

Reuters
03-27
Bausch + Lomb recalls some of its implantable eye lenses

March 27 (Reuters) - Bausch + Lomb BLCO.TO said on Thursday it will recall some of its implantable eye lenses after receiving reports of complications, the cause of which could not immediately be known.

The company said it is recalling these lenses, which are part of its enVista platform, out of an abundance of caution, and was looking to identify a root cause.

"As much as we believe in the enVista platform, patient safety will always be our number one priority," said CEO Brent Saunders.

The company's intraocular or surgically implanted lenses are used in cataract surgery to replace the natural clouded lens in the eye.

Bausch + Lomb said there have been reports of an inflammatory reaction in some patients with these lenses, adding the patients responded quickly to treatment, with none requiring removal of the lens.

The company said it is informing eye care professionals about the impacted lots and return protocols for the product.

(Reporting by Christy Santhosh in Bengaluru; Editing by Shailesh Kuber)

((Christy.Santhosh@thomsonreuters.com;))

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10